For further information on COVID-19 please click here.
UHCW are working with colleagues in the UK and all around the world in the fight against COVID-19. Patients who have COVID may be invited to take part in these studies if they meet the inclusion criteria.
We are also taking part in a number of studies looking at the impact of COVID on patients and services at the Trust, which we may ask patients to participate in.
Patients are under no obligation to take part, and their standard care will not be affected if they decide not to take part.
Some of the studies we are currently conducting are below.
This study aims to prospectively capture clinical/laboratory data from the UHCW post-Covid-19 clinical pathway in order to characterise the residual problems and relevant healthcare needs of patients that recovered from COVID-19.
Find out more here
Valneva’s Phase three clinical trial will test a new vaccine candidate against Covid-19. This study will investigate the level of antibodies against Covid-19 induced by the vaccine candidate VLA2001 and whether it is safe to use. Volunteers will receive two doses of the vaccine four weeks apart and are required to attend up to eight follow-up visits over 13 months. Inconvenience payments will be available.
Find out more here.
This study aims to find out whether a single online session of exercise advice and support or an 8 week online exercise and support programme is better for helping people recover after being in hospital with Covid-19.
This trial aims to explore the effectiveness of a new drug taken orally, called IMU-838, in combination with Oseltamivir (Tamiflu) – one of the most widely used flu treatments in the UK – in patients with confirmed or suspected Covid-19.
The ACCORD platform will test several different drugs to understand how they improve clinical outcomes in patients admitted to hospital with Covid-19. If positive results are seen, these drugs will be included in large-scale Covid-19 trials such as the RECOVERY trial.
GenOMICC is a research study that looks at the DNA of people with severe infections and injuries. Our genes (DNA) can determine how much critical illness affects us. We want to find the genes that cause some people to be more sick. If we do, we may be able to develop better treatments for patients in the future.
This is an international adaptive platform trial in community acquired pneumonia, that was specifically designed to be employed in a pandemic to evaluate multiple interventions simultaneously in critically ill patients.
This is a clinical trial looking at the effects of a medication called canakinumab on patients with Covid-19 pneumonia (an infection in one or both lungs). Patients who take part will be randomised to receive either canakinumab or placebo.
This is a clinical trial looking at whether Eicosapentaenoic acid (EPA-FFA) gastro-resistant capsules can reduce the inflammation in the lungs of people with Covid-19 infection and also whether it prevents more serious lung problems developing.
This study aims to monitor children and young people who have a condition or are taking medication that affects their immune system and makes them more vulnerable to infections during the coronavirus pandemic. Parents of immunosuppressed children, and the children and teenagers themselves, record their experiences of viral respiratory illnesses including Covid-19 on an online questionnaire.
The purpose of the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) is to prevent illness and deaths from infectious disease outbreaks. This research aims to study Covid-19 to better understand its spread and behaviour. This will be done by collecting and analysing biological samples and data from patients with confirmed cases of the disease across the UK.
PAN COVID is a global registry of women with suspected or confirmed Covid-19 infection in pregnancy and their newborn babies.
This national clinical trial aims to identify treatments that may be beneficial for people who have been admitted to hospital with suspected or confirmed Covid-19.
This study uses the UK Obstetric Surveillance System (UKOSS) to collect information about pregnant women who are admitted to hospital with confirmed Covid-19 infection, their health and the health of their baby or babies.
Back
IMPORTANT INFORMATION ON BLOOD TESTING DUE TO COVID-19
If you are experiencing symptoms associated with COVID-19, e.g. fever, loss of taste or continuous new cough, please DO NOT attend for a blood test.
Click on the map for information about phlebotomy clinics in Coventry. You can book an appointment online at the locations in red.
Please book an appointment before attending for a blood test. Click on the ‘Book Online’ button above. Booking an appointment helps patients, their carers and family members to plan their hospital visit better, helping to reduce clinic waiting times and enabling patients to be seen much more quickly.
Location: Outpatients Department, on the ground floor. Opening hours: 8am-4.45pm, Monday to Friday (excluding bank holidays).
Children under 16 years old will need to book online here.
Please book an appointment before attending for a blood test, click on the ‘Book Online’ button above. Patients from Rugby and the surrounding areas are able to access the Friends Blood Taking Unit at the Hospital of St Cross.
Referrals for blood tests can be from GP's, practice nurses or from hospital consultants. Patients are also able to leave other samples, such as urine, which have been collected at home, at the hospital's Pathology Reception.
Location: Near Brookfield House, just off North Road - map here. Opening hours: The blood taking clinic sessions for adults and children are listed below:
Monday -Friday 7am-4:45pm Appointment only
Wednesday Evening 5pm-7pm Suspended due to COVID
Saturday Morning 7am-10pm Suspended due to COVID
April 2020 NEW - This Clinic is now by appointment. Please book an appointment before attending for a blood test. Click on the ‘Book Online’ button above.
Address: Stoney Stanton Road, Coventry CV1 4FS Location: Access is via the main doors, the Phlebotomy team are in Area A. Opening hours: Monday to Friday (excluding bank holidays). 8am–4.45pm
Glucose Tolerance Test (GTT)
Specialist Tests - There are a small number of specialist tests where blood needs to be taken on a hospital site as the sample must be transferred to the laboratory rapidly for the test to be undertaken. Click here for a list of these specialist tests and to find out more.